Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide

Background. The development of 2 unassociated brain cancers in the same patient is a rare occurrence. Secondary cancers are generally thought to develop as an oncogenic consequence of the radiation therapy delivered to treat the primary cancers, always requiring a significant time interval between r...

Descripción completa

Detalles Bibliográficos
Autores principales: Alotaibi, Fahad E., Petrecca, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773383/
https://www.ncbi.nlm.nih.gov/pubmed/24073000
http://dx.doi.org/10.1155/2013/591272
_version_ 1782284406859235328
author Alotaibi, Fahad E.
Petrecca, Kevin
author_facet Alotaibi, Fahad E.
Petrecca, Kevin
author_sort Alotaibi, Fahad E.
collection PubMed
description Background. The development of 2 unassociated brain cancers in the same patient is a rare occurrence. Secondary cancers are generally thought to develop as an oncogenic consequence of the radiation therapy delivered to treat the primary cancers, always requiring a significant time interval between radiation treatment and secondary cancer development. Case Description. We report the development of an undifferentiated myxoid sarcoma only 13 months following radiation therapy for a glioblastoma. Conclusion. This case represents the shortest time interval reported between radiation therapy and secondary brain cancer development.
format Online
Article
Text
id pubmed-3773383
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37733832013-09-26 Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide Alotaibi, Fahad E. Petrecca, Kevin Case Rep Med Case Report Background. The development of 2 unassociated brain cancers in the same patient is a rare occurrence. Secondary cancers are generally thought to develop as an oncogenic consequence of the radiation therapy delivered to treat the primary cancers, always requiring a significant time interval between radiation treatment and secondary cancer development. Case Description. We report the development of an undifferentiated myxoid sarcoma only 13 months following radiation therapy for a glioblastoma. Conclusion. This case represents the shortest time interval reported between radiation therapy and secondary brain cancer development. Hindawi Publishing Corporation 2013 2013-08-29 /pmc/articles/PMC3773383/ /pubmed/24073000 http://dx.doi.org/10.1155/2013/591272 Text en Copyright © 2013 F. E. Alotaibi and K. Petrecca. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Alotaibi, Fahad E.
Petrecca, Kevin
Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
title Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
title_full Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
title_fullStr Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
title_full_unstemmed Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
title_short Short Interval Infield Sarcoma Development following Resection of Glioblastoma and Adjuvant Radiotherapy and Temozolomide
title_sort short interval infield sarcoma development following resection of glioblastoma and adjuvant radiotherapy and temozolomide
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773383/
https://www.ncbi.nlm.nih.gov/pubmed/24073000
http://dx.doi.org/10.1155/2013/591272
work_keys_str_mv AT alotaibifahade shortintervalinfieldsarcomadevelopmentfollowingresectionofglioblastomaandadjuvantradiotherapyandtemozolomide
AT petreccakevin shortintervalinfieldsarcomadevelopmentfollowingresectionofglioblastomaandadjuvantradiotherapyandtemozolomide

Ejemplares similares